Author:
Batey Michael A.,Vormoor Josef H.
Reference69 articles.
1. Lee EM, Bachmann PS, Lock RB. Xenograft models for the preclinical evaluation of new therapies in acute leukemia. Leukemia and Lymphoma, 2007. 48(4):659–668.
2. Sausville E, Burger AM. Contributions of human tumour xenografts to anticancer drug development. Cancer Research, 2006. 66:3351–3354.
3. Kerbel RS. Human tumour xenografts as predictive preclinical models for anticancer drug activity in humans: better than commonly perceived – but they can be improved. Cancer Biology Therapy, 2003. 2:134–139.
4. Khanna C, Hunter K. Modelling metastasis in vivo. Carcinogenesis, 2005. 26:513–523.
5. Lozzio BB, Machado EA, Lozzio CB, Lair S. Hereditary asplenic-athymic mice; transplantation of human myelogenous leukemic cells. Journal of Experimental Medicine, 1976. 143:225–231.